Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

NCT02581384 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT02581384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02581384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2017
Completion date
August 31, 2020
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, ewing sarcoma, non-rhabdomyosarcoma soft tissue sarcoma, nos, osteosarcoma, renal tumor, rhabdoid tumor, rhabdomyosarcoma, sarcoma, sarcoma, ewing, soft tissue sarcoma, wilms tumor